Genmab and argenx combine antibody know-how
Genmab and argenx have entered a multiyear collaboration bringing together capabilities to jointly discover, develop and commercialise antibody therapies.
Adaptyv Biosytems launches protein engineering foundry
Swiss Adaptyv Biosystems Sàrl has launched two fast-feedback tools that allow cheap, rapid and minaturised validation of AI-designed proteins.
Researchers activate chemotherapeutics by ultrasound
Ultrasound that switches cancer drug on could significantly reduce chemotherapy side effects, German researchers found in preclinical studies.
FAO presents food safety assessment on cell-based protein products
At the beginning of April, the FAO presented a report entitled "Food safety aspects of cell-based food" to establish safety standards for cell-based proteins.
Mosaic Therapeutics closes $28m series A financing
Wellcome Sanger Institute spin out Mosaic Therapeutics has closed a $28m series A funding led by Syncona Investment Management Ltd, and Cambridge Innovation Capital.
Carbios SAS set to licence and expand PET recycling
French enzymatic polyethylene therephtalate recycler Carbios SAS has published a licensing documentation for global commercial deployment of its biorecycling technology.
Insempra and Axxence launch alpha-ionone
Precision fermentation specialist Insempra GmbH has inked a supply deal with Axxence Aromatic GmbH for alpha-Ionon, a natural flavour and fragance ingredient.
German-Chinese ADC collaboration
BioNTech has entered the ADC field with an exclusive license and collaboration agreement with Chinas DualityBio Ltd for two antibody-drug conjugate (ADC) assets.
Nomi Biotech presents natural additive to preserve probiotics
Researchers from Polish-Japanese Nomi Biotech sp zoo have presented evidence that that probiotic yogurt can be conserved without artificial preservatives.
LSP Dementia Fund closes at 260m
EQT Life Sciences has closed the LSP Dementia Fund at approximately 260m, 2.6-fold over the target fund size of 100m.